PHARmACEuTICAl INDuSTRY
Transcription
PHARmACEuTICAl INDuSTRY
pharmaceutical INDUSTRy In Morocco EXHIBITOR’S DIRECTORY CPHI / PARIS / October, 7 - 9, 2014 Quality IS OUR COMMITMENT OUR EXHIBITORS MADE IN MOROCCO 7 ABOUT US 15 OVERVIEW 23 EXHIBITORS LIST TABLE OF CONTENTS About US MAROC EXPORT Who Are We? The Moroccan Center for Export Promotion is a governemental institution founded on December 17, 1976 (Hija 25, 1396) by Dahir NO 1-76-385. MAROC EXPORT endowed with a legal responsibility and financial auto- nomy, it also under the super vision of delegate Ministry to the Ministry of Industry, Trade, Investment and Digital Economy in charge of foreign trade. The Center is in charge of promoting the export of industrial and agricultural products, services, and any products that do not fall under the jurisdiction of other administrations or organizations, by virtue of law or regulation. In fact, handicrafts and tourism promotion are governed respectively by The House of Handicrafts and the national Office of Tourism. 8 CONTACT Zahra MAAFIRI Managing Director Nadia RHAOUTI Sectoral Manager [email protected] Hasnaa ALAOUI Communication Manager [email protected] Mouizz EL ALAMI Head of Department Global Trades of Morocco [email protected] AdDress 5, Rue Sidi Belyout (Angle Avenue des FAR), 20000 Casablanca - Morocco Phone : +212 522 302 210 +212 522 307 588 Fax : +212 522 450 557 E-mail : [email protected] Website : www.marocexport.gov.ma f : Centre Marocain de Promotion des Exportations 9 OUR MISSIONS Promoting Moroccan exportable goods in international markets, in accordance with national sectorial strategies; Expanding markets for Moroccan exports; Supporting the internationalization of Moroccan companies; Organizing business information systems at the international level, in collaboration with economic and trade representations abroad; Conducting studies on the exportability of Moroccan products and on the characteristics of foreign markets; assisting exporters in their marketing efforts and advertising Moroccan products abroad; 10 Providing input in the development of global trade policies and a consistent program for promoting the exportation of manufactured products; Assisting export-promotion, credit system and export credit insurance institutions, simplifying and standardizing export-related documentation and procedures; Guiding public and private investors towards products that can be quickly assimilated into foreign markets with the best possible conditions; Contributing to the training of foreign trade professionals in export promotion techniques, information and marketing; 11 OUR ACTIVITIES 12 We organize Moroccan participation to professional international sector-based fairs to increase international exposure for the products and services oriented export; Our Sectorial communication campaigns guarantee a better positioning of the Moroccan products and services oriented export on international markets; We set up business missions with B-to-B meetings for direct marketing towards foreign customers in targeted markets; Our Business-to-Consumer (B-to-C) operations facilitate the referencing of Moroccan agricultural products with major international retail chains; Our high level institutional missions target decision makers of major international prime contractors in order to strengthen their sourcing from Morocco. We invite foreign decision makers to Morocco in order to promote Moroccan quality and know-how. Our large-scale multi-sectorial missions facilitate the penetration of Moroccan exporters into the sub-Saharan and MENA markets; We conduct training and information sessions to help identify the Moroccan products and services oriented export. 13 Overview MOROCCAN PHARMACEUTICAL INDUSTRY KEY FIGURES IN 2013 Medicines consumption in 2013 Medicines consumption in Morocco has reached 414 Dh per inhabitant in 2013 and 9.1 units per person. Evolution of the number of production units Years 2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013 Number of production units Source : AMIP 26 27 30 35 35 35 35 35 32 32 32 32 TOP 10 OF THERAPEUTIC CLASSES IN UNITS (2013) Evolution of the number of units produced 2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013 Years Quantity (in million of units) 186 188 185 192 203 227 259 279 282 293 303 307.4 Source : IMS HEALTH Evolution of the number of units produced (5 years scale) Years Quantity (in million of units) Source : IMS HEALTH 4.6 4.7 Market share in % of value Morocco 8 977 074 100,0% APP DIGESTIVE METABOLISM 1 642 954 18,3% GENERAL ANTIINFECTIVES 1 386 577 15,4% NERVOUS SYSTEM 1 070 320 11,9% 1995 2000 2005 2010 APP CARDIOVASCULAR 990 320 11,0% 104 130 155 178 192 282 BREATHING APPARATUS 719 777 8,0% musculoskeletal system 686 101 7,6% APP GENIT-URIN.HORM.SEX 639 961 7,1% DERMATOLOGY 404 443 4,5% SENS ORGANS 354 974 4,0% Others 1 081 648 12,0% 2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013 4.5 Dirhams per year 2013 (in Thousands of Dh) 1990 Industry’s turnover (2002 – 2013) Value (in Billion Dh) Therapeutic classes in values 1985 source : IMS HEALTH Years All therapeutic classes are covered by local production, digestive system drugs, metabolism, anti-infective, central nervous system and apparatus and cardiovascular drugs predominate in Moroccan consumption. These classes represent more than half the market in units and values. 4.9 5.3 6.1 7 7.8 7.9 8.3 8.7 8.9 Source : IMS HEALTH 16 17 TOP 10 OF LABORATORIES IN VALUES IN 2013 Values in Dh MAROC 8 977 073 750 831 411 470 SANOFI-AVENTIS 805 245 636 COOPER MAROC 774 063 569 664 690 943 MAPHAR LAPROPHAN 664 130 738 593 876 569 BOTTU S.A. 524 540 609 GSK 387 083 494 GALENICA 299 647 396 NOVARTIS PFIZER MAROC 307 477 752 SOTHEMA TOP 10 OF PRODUCED MEDICINES IN UNITS AND VALUES (2013) Units produced per year Evolution compared to 2012 in % Units in Dirhams per year Evolution compared to 2012 in % MOROCCO 307 431 075 1,5 8 977 073 749 2,6 DOLIPRANE 18 676 697 1 479 901 1 774 822 1 845 178 3 441 634 1 709 955 1 465 578 855 762 11,4 -3,9 11,7 -4,2 11,0 -2,5 13,2 15,0 162 483 299 121 877 272 75 812 080 67 660 092 61 570 832 57 493 299 56 365 271 55 024 904 11,1 -2,5 13,5 -4,0 11,0 -2,2 22,0 15,8 AUGMENTIN OEDES AMOXIL MICRODIOL VENTOLINE ERECTOR CLAVULIN Source : IMS HEALTH Source : IMS HEALTH Market share Evolution in % 100,0 9,3 9,0 8,6 7,4 7,4 6,6 5,8 4,3 3,3 3,4 2,6 6,4 -1,1 6,1 0,9 -2,6 11,8 -1,4 1,0 3,1 -1,1 Units Market share Evolution 307 431 075 24 736 981 20 585 963 31 594 830 26 595 925 22 430 373 33 507 252 10 495 262 22 348 611 8 624 994 8 484 625 100,0 8,0 6,7 10,3 8,7 7,3 1,5 4,1 -1,0 3,4 -0,2 -6,1 9,1 -4,4 2,6 2,0 2,0 10,9 3,4 7,3 2,8 2,8 TOP 10 OF LABORATORIES IN UNITS PRODUCED IN 2013 Market share Evolution Values in Dh UNITS Market share in % Evolution MAROC 307 431 075 100,0 1,5 8 977 073 750 100,0 2,6 BOTTU S.A. 33 507 252 10,9 9,1 593 876 569 6,6 11,8 COOPER MAROC 31 594 830 10,3 3,4 774 063 569 8,6 6,1 MAPHAR 26 595 925 8,7 -0,2 664 690 943 7,4 0,9 SOTHEMA 24 736 981 8,0 4,1 831 411 470 9,3 6,4 LAPROPHAN 22 430 373 7,3 -6,1 664 130 738 7,4 -2,6 GALENICA 22 348 611 7,3 2,6 387 083 494 4,3 1,0 SANOFI-AVENTIS 20 585 963 6,7 -1,0 805 245 636 9,0 -1,1 PHARMA 5 13 370 625 4,3 3,4 302 346 909 3,4 2,0 BAYER MAROC 11 836 669 3,9 -0,1 259 603 910 2,9 -3,8 GSK 10 495 262 3,4 -4,4 524 540 609 5,8 -1,4 Source : IMSHEALTH 18 19 GENEREIC AND ORIGINATORS IN UNITS AND VALUES IN 2013 Units in 2013 Values in 2013 Evolution PM % Units (in thousands ( in thousands 2012/2013 of units) of Dh) Evolution 2012/2013 PM % Values Morocco 307 426,6 1,5 100,0 8 976 291 2,6 100,0 Generics 97 856,9 4,1 31,8 2 987 713 6,7 33,3 Originators 209 569,7 0,4 68,2 5 988 578 0,7 66,7 Source : IMS HEALTH Generics are present substantially at antibiotics drugs, digestive system medicines, metabolism drugs, cardiovascular drugs, musculoskeletal and nervous system drug as well as in medications fo the respiratory tract. 20 Summary of the key figures of 2013 : The Moroccan pharmaceutical industry is, by its size, second place across the African continent, after South Africa, with 32 industrial units, 50 distributors and more than 11,000 pharmacies. Local production covers 65% of domestic demand and the country exports 7-8% of its production, in particular to neighboring African countries. Morocco is ranked Zone Europe by the World Health Organization, based on the quality of manufactured drugs. The Moroccan pharmaceutical industry provides today nearly 40,000 direct and indirect jobs, and satisfies nearly all national needs in medicines, as it currently produces 307.4 million units. Based on the latest statistics from the International Medical Statistics (IMS), the Moroccan pharmaceutical industry generates on the private market an annual turnover of 8.9 billion dirhams. 21 EXHIBITORS LIST Contact Zakaria AMAJJARKOU Export Manager AdDress Route côtière Casablanca Mohamedia, N°111 km 12.400 Ain Harrouda, 28 630 Casablanca, Morocco Phone : +212 522 662 915 Fax : +212 661 662 919 E-mail : [email protected] Website : www.aphricphar.net Products Eucarbon Dipicor Nocol Tecpril Nomyc Unizitro Catex 24 Charbon végétal Amlodipine Simvastatine Ramipril Fluconazole Azithromycine Ciprofloxacine AFRIC PHAR Founded in 1966, The AFRICPHAR laboratory is one of the first of Morocco’s pharmaceutical industry. The AFRIC-PHAR laboratory ensures the import, manufacture, marketing, export and distribution of pharmaceuticals. The AFRIC-PHAR laboratory is accredited by Ministry of Public Health is certified QSE (Quality, Safety and environment) by AFNOR International. with the health authorities. Very dynamic and strong field force presence in Morocco, with full coverage of GP’s and different specialist with high frequency visit. Contract Manufacturing Services for solid and liquid dosage forms and creams. Contract Manufacturing Services for oral Cephalosporin products. We are interested in: We offer: Excellent Know-how in Regulatory affairs, with very good contacts In-licensing/Sublicensing of branded or generic pharmaceutical product. Contact Lamia BERRADA CEO Samir BACHOUCHI General Manager Youssef BEN ESSALAH Client Relationship Manager Layla HMAOUI Operations Manager Ahmed KATHIR Export Manager Habib CHRIFI Purchase Manager Fouad HASBAOUI Import Manager Address 82, Allée des Casuarinas, Ain Sebaa 20250 Casablanca, Morocco Phone : +212 522 355 350 Fax : +212 522 356 419 E-mail : [email protected] Website : www.bottu.com 26 BOTTU Founded in 1952, BOTTU SA ranks 1st among Moroccan laboratories in volume with more than 40 Million units produced per year, and a capacity of 60 Million units. BOTTU SA masters the latest technologies related to Drug Manufacture and respects the highest quality standards. Besides Marketing its own portfolio of Generic products, BOTTU SA markets products under License Agreements of renowned Multinational Companies such as Boehringer Ingelheim, Sanofi, Abbott, Boiron, Johnson&Johnson,… Export-oriented since 2008, BOTTU SA is developing its business within Western and Eastern Africa, GCC, CIS countries and South America. Contact Zaineb KETTANI Manager Communication & Events Amine HAJOUI Senior Manager International Business Development Mustapha EL BELOUI Senior Manager Exports Address 41, Rue Mohammed Diouri Casablanca, Morocco Phone : +212 522 453 200 Fax : +212 522 304 853 E-mail : [email protected] [email protected] Website : www,cooperpharma.ma 28 COOPER PHARMA Cooper Pharma has been present for more than 80 years in the pharmaceutical industry to serve a mission that is “Increasing everybody’s access to pharmaceutical drugs”. Today, Cooper Pharma is the leading Moroccan pharmaceutical company, proposing more than 100 pharmaceutical specialties of its branded generics portfolio in the major therapeutic areas. Alongside with its own brand, Cooper Pharma manufactures, imports, markets and promotes a hundred of drugs under license from more than 20 international companies. Cooper Pharma represents a unique model in Morocco with its triple activity: producer, distributor and exporter of pharmaceutical specialties. This model is based on an industrial tool at the cutting edge of technology, certified by the leading health authorities. In addition, Cooper Pharma is also involved in human and social development in Morocco, by contributing through several corporate citizenship activities, in the areas of Health, Education and Environment. GALENICA Contact Salim ELGUERMAI CEO - Responsible pharmacist AdDress N° 13, GP 5-ZI Oulad Saleh-Bouskoura 20180 Casablanca, Morocco Phone : +212 522 859 999 Fax : +212 522 320 303 E-mail : [email protected] [email protected] Website : www.galenica.ma Products Difal Sodium diclofenac CetamylAcetaminophen NeomoxAmoxicillin Biotic plus Amoxillin, Clavulanic, Asid AZ Azithromycin Claril Clarithromycin Penistaph Sodium Diclofenac Gastrogel AL-MG Hydroxydes Ranitil Ranitidine IPP Omeprazol Beviran Mebeverine Candicid Fluconazol DolamineAcetaminophen Caffein + Promethazine Rhumix Acetaminophen, Ibuprofen, Pseudeophedrin, Caffein, Vitamin C, Chlorphenamine 30 Based in Casablanca/Morocco, GALENICA Pharmaceutical Laboratories have been established in 1978 and figure in the top 5 leading pharmacompanies in its country. solutions. Semi-liquid forms : suppositories, creams, ointments. GALENICA is specialised in the development, the registration, the manufacturing and the sales & marketing of pharmaceutical drugs and cosmetics. Its new plant, fully complying with cGMP/ BPF standards, over 24,000 sqm including modern and reliable equipment and based on a performant quality management system, providing a strong manufacturing capacity with the requested quality and flexibility. Pain management and antiinflammatories, Cardiovascular CVS, Gastroenterology, Antibiotics and anti-infectious, Metabolism and antidiabetics, Respiratory and antitussive, OTC. 50 million units / year capacity. Betalactamines penicillin separated unit. Solid dosage forms : capsules, tablets, coated tablets, bags, powders for suspensions. Liquid forms : syrups, suspensions, Wide range of products over important therapeutical fields : Staff of 450 people including sales and marketing team (120 people). GALENICA can figure as a reliable partner for : Under licence and contract manufacturing for the moroccan and the foreign markets. The supply of drugs in national or NGO health programs and tenders. the pharmaceutical development of new drugs. GENPHARMA Contact Amine MEZDANI Senior Business Area Manager Mhammed EZZERROUTI Purchasing Manager AdDress 254-256 Zone Industrielle El jadida 24000 El jadida, Morocco Phone : +212 523 352 983 Fax : +212 523 352 993 E-mail : [email protected] Website : www.genpharma.ma ProduCts ACEPIL PLUS Perindopril + Indapamine ACEPRIL Perindopril AMCARD Amplodipine LEVAQUIN Levofloxacin LOMET Lansoprazole LOSACAR Losartan+HTZ MARVIL Olanzapine OMEGEN Omeprazole SUPRALER Levocetirizine 32 Established in 2001, Genpharma is a pharmaceutical company specialized in the development, production and marketing of generic medecine. Our headquarter is located in El Jadida (Morocco) where Genpharma has GMP approved production unit, R&D, marketing and distribution center. With a production capacity of 120 million boxes, Genpharma has an objective to expand and grow its strategic position as a leader in the moroccan generic market. oral solid form, controlled-release form and injectables. With our expertise in the production from Active Pharmaceutical Ingredient (API) till finished product, Genpharma can guarantee to all their customers and partners, large volume of world class medicine at affordable price, dedicated and cooperative customer’s services. Genpharma has also a strong pipeline of products under development and a large number of products waiting regulatory approval. Since 2006 Genpharma made their international presence in 20 countries in Africa and Middle East. Over 25% of total sale are now contributed by international operations. Genpharma’s production capacity can ensure 120 million boxes per year, our customers can be ensured of reliable delivery of our products and our ability to meet high demand. Our products cover a wide range of therapeutic areas offering with different galenic forms : Our uniformed network of manufacturing facilities and vertically integrated distribution guarantees satisfaction for all your needs. Contact Dr. Danielle TOBIAS Export Manager Address 18 Bd Emile Zola Casablanca, Morocco Phone : +212 522 543 838 Fax : +212 522 444 397 E-mail : [email protected] Website : www.laprophan.ma LAPROPHAN Pionnier et leader de l’Industrie pharmaceutique nationale depuis 1949 ProduCts Plus de 65 ans au service de la Santé : NeofortanPhloroglucinol Di-indo Indométacine, Calcique, Pentahydrate Ixor Oméprazole Parasphan Paracétamol, Caféine Acide Acétylsalicylique, Myantalgic Tramadol, Paracétamol Levamox Amoxicilline, Acide Clavulanique Centre de R&D où sont développées des spécialités ayant des brevets internationaux d’invention. 34 Fabricant d’une gamme diversifiée de plus de 400 spécialités (Gamme propre et sous-licence). Présence en Afrique, en Europe et au Moyen-Orient. Centre de Distribution sophistiqué, équipé de NTIC et d’une infrastructure logistique de pointe. Partenaire des plus grands Laboratoires Internationaux Reconnaissance Internationale (Agrément AFSSAPS, Prix d’Excellence OMPI 2008 Genève, ler Prix 2008 de l’Innovation R&D Maroc, Prix d’Excellence du Développement Humain Durable FSMD 2010 - Genève ...) MC PHARMA Contact Abderrahman HASSOUNI Chairman Mohamed Drissi Queytour General Manager Address Bachkou, rue 7, lot 10 Casablanca, Morocco Phone : +212 522 853 518 Fax : +212 522 824 490 E-mail : [email protected] 36 MC PHARMA is a Moroccan based pharmaceutical company and expert in developing, manufacturing and marketing oral solid dosage forms including effervescent, water-soluble granules and orally disintegrating tablets. For over 10 years, we have been working with pharmaceutical companies and producers of food and dietary supplements to expand their product lines. MC PHARMA developed numerous products including antacids, analgesics, cough and cold and combinations thereof, vitamins, mineral combinations as well as herbal extracts. We work with pharmaceutical and nutraceutical companies through different cooperation models: New products development - licensing market-ready products and manufacturing outsourcing. PHARMA 5 GROUP Contact BENCHEKROUN Nabil Sales Manager Tarik MHAIMER Export Manager ADdress 21, Rue des Asphodeles, Maarif Extension Casablanca, Morocco Phone : +212 522 593 939 +212 522 593 940 E-mail : [email protected] Website : www.pharma5.ma ProduCts Aclav, Astaph, Alfamox, Rinomicine, Nuravit, Bidontogyl, Canaflucan, Nauselium, Macromax, Diclo, Clartec, Algofene, Eumoxol, Megasfon 38 A GROWING COMPANY With a portfolio of more than 350 pharmaceutical presentations, distributed on several therapeutic ranges and presented in all forms, Pharma 5 was able to record an annual average growth of 23 % since its creation in 1985. Pharma 5 employs more than 1000 persons with a rate of supervision ratio superior to 30 %. Built on more than 20 years of successful presence, Pharma 5 laboratories set up a new production unit that includes the most successful technological qualities, for a total investment of dirhams 210 million. A REFERENCE IN QUALITY CONTROL With 40 service managers and last generation technological and scientific equipment, they have a control laboratory which constitutes a national reference in terms of quality control. Compliant with the Good Manufacturing practices, the industrial unit has settled as an objective to meet the quality requirements of international agencies with the aim to obtain the approval of the Food and Drug Administration (FDA - USA) and the French Agency of Sanitary Security the Health Products (AFSSAPS - France). In 2009 and 2010, Pharma 5 was the only Moroccan private laboratory to participate to interlaboratories tests organized by the EDQM (European Directorate for the Quality of Drug) The results have always been positive. R&D : A SPEARHEAD IN THE POLITIC OF GROWTH All department activities take place in a very strict regulatory framework set by the Moroccan health authorities following the AFSSAPS (french health product safety agency) themselves, the WHO (World Health Organisation), the GMP Good Manufacturing Practices and the ICH. Endowed with human and technological resources of great competence, performance and polyvalency, this department is engaged, within the framework of its missions, in a partnership with national and international renowned experts in collaboration with faculties of medicine and pharmacy in an exchange as well as centers of bioanalytical allowing Pharma 5 to highlight its knowledge. Besides, the eclectic nature of Pharma 5’s R&D department ensures new perspectives of development and new opening opportunities in the field of academic research. EXPORT AS A KEY DRIVER Pharma 5’s focus on developping a new businesses allowed them to expand their presence in new markets (France, Ivory Coast, Senegal, Cameroon, Mali, Gabon, Burkina Faso, Benin, Togo, Republic of Congo ‘Brazzaville’, Democratic Republic of the Congo ‘Kinshasa’, Mauritania, Guinea, Niger, Algeria, Iraq, Libya, Madagascar, Mauritius, etc…). Pharma5 is now present in more than 35 countries (8% of Group’s total revenues made outside Morocco) and has the commercial strength that allows it to increase its footprint in new markets outside Morocco. Moreover, Pharma 5 is the first and only Moroccan pharmaceutical company that is entitled to market its product within the GCC (Gulf Cooperation Council : Saudi Arabia, United Arab Emirates, Kuwait, Oman, Bahrain and Qatar) as well as Yemen and Sudan. Contact Hassan HADDA Sales Manager Address R.S.203, ROUTE OUED AKREUCH, OUM AZZA - B.P. 4491 - 12100 Aïn El Aouda Casablanca, Morocco Phone : +212 537 748 284 Fax : +212 537 748 639 E-mail : [email protected] Website : www.phi.ma ProduCts Vigorex Medizapin S-citap No-dep Anginib Calcinib Cardix Co-anginib Oxygenor Alzole 40 Lanprol Uradox Agifene Oxiden Neocip Oloxine Nofloxine Airlix Mycoflu Onifine PHARMACEUTICAL INSTITUTE PHARMACEUTICAL INSTITUTE Laboratory (created in 1989) is the result of a synergy between two founders deeply acting in the Pharmaceutical field. With its new GMP plant, and its powerful team, PHI first has developed partnerships with major interna- tional pharmaceutical companies. And Since ten years, PHI has launched its own range of generic drugs first generic products in their class. And, Recently, PHI began developing its export business to African countries. Ministry Delegate to the Minister of Industry Trade, Investment and the Digital Economy in charge of Foreign Trade 63, Avenue Moulay Youssef, 10000 Rabat - Morocco Phone : (+212) 537 706 321 - (+212) 537 706 389 Fax : (+212) 537 703 231 Embassy of the Kingdom of Morocco in Paris - France 5, rue Le Tasse, 75016 Paris Phone : (+33) 0 145 206 935 Fax : (+33) 0 145 202 258 E-mail : [email protected] Website : www.amb-maroc.fr Moroccan Center for Export Promotion 5, Rue Sidi Belyout (Angle Avenue des FAR), 20000 - Casablanca - Morocco Phone : (+212) 522 302 210 - (+212) 522 307 543 Fax : (+212) 522 450 557 - (+212) 522 301 793 Website : www.marocexport.gov.ma E-mail : [email protected] f : Centre Marocain de Promotion des Exportations